Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Pediatric optic neuritis.
Altered Serum Cytokine Profiles in Relapse Phase of Relapsing-Remitting Multiple Sclerosis.
Haematopoietic stem cell transplantation in autoimmune diseases: From basic science to clinical practice.
Immunological processes related to cognitive impairment in MS.
Thrombomodulin dependent protein C activation is required for mitochondrial function and myelination in the CNS.
Expression of brain-derived neurotrophic factor in astrocytes - Beneficial effects of glatiramer acetate in the R6/2 and YAC128 mouse models of Huntington's disease.
In Vitro Functional Assessment of Adult Spiral Ganglion Neurons (SGNs).
Evaluation of species difference in peripheral lymphocyte reduction effect by CS-0777, a sphingosine 1-phosphate receptor modulator, based on a pharmacokinetic/pharmacodynamic model analysis.
Survival and Functionality of Human Induced Pluripotent Stem Cell-Derived Oligodendrocytes in a Nonhuman Primate Model for Multiple Sclerosis.
Upper Respiratory Infections and MRI Activity in Relapsing-Remitting Multiple Sclerosis.
An update on the evidence base for peginterferon β1a in the treatment of relapsing-remitting multiple sclerosis.
Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - YES.
The Adaptor Protein Rai/ShcC Promotes Astrocyte-Dependent Inflammation during Experimental Autoimmune Encephalomyelitis.
Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: A case report and review of literature.
Oculomotor Nerve Palsy as a Rare Presentation and First Sign of Multiple Myeloma.
Multiple sclerosis: Molecular mimicry of an antimyelin HLA class I restricted T-cell receptor.
A review of the ethics of the use of placebo in clinical trials for relapsing-remitting multiple sclerosis therapeutics.
A multi-biomarker follow-up study of patients with multiple sclerosis.
The obesity-related pathology and Th17 cells.
Major Superficial White Matter Abnormalities in Huntington's Disease.
Individualized Rituximab Treatment for Neuromyelitis Optica Spectrum Disorders.
Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy.
SLE Neuropathy-Anything New?
Recovery from optic neuritis attack in neuromyelitis optica spectrum disorder and multiple sclerosis.
Comparisons of the efficacy and tolerability of mycophenolate mofetil and azathioprine as treatments for neuromyelitis optica and neuromyelitis optica spectrum disorder.

Pages